Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Klimek

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Bone Marrow Transplantation|August 24, 2018
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerRichard J Lin, Theresa A Elko, Miguel-Angel Perales, et al.
The New England Journal of Medicine|November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatmentMargaret K Callahan, Raajit Rampal, James J Harding, et al.
Cell Transplantation|June 9, 2009
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human isletsJames D Johnson, Ziliang Ao, Peter Ao, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet TransplantsJaques A Courtade, Agnieszka M Klimek-Abercrombie, Yi-Chun Chen, et al.
British Journal of Haematology|January 10, 2006
Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myelomaHani Hassoun, Lilian Reich, Virginia M Klimek, et al.
BMJ Open|June 27, 2023
Music to prevent deliriUm during neuroSurgerY (MUSYC): a single-centre, prospective randomised controlled trialPablo R Kappen, M I Mos, Johannes Jeekel, et al.
The Lancet. Haematology|August 1, 2020
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trialJustin Taylor, Xiaoli Mi, Alexander V Penson, et al.
Nature Biotechnology|March 24, 2015
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cellsAndriana G Kotini, Chan-Jung Chang, Ibrahim Boussaad, et al.
Cancer Discovery|March 5, 2014
Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignanciesOmar Abdel-Wahab, Virginia M Klimek, Alisa A Gaskell, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet graftsK J Potter, A Abedini, P Marek, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|August 24, 2018
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer centerRichard J Lin, Theresa A Elko, Miguel-Angel Perales, et al.
The New England Journal of Medicine|November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatmentMargaret K Callahan, Raajit Rampal, James J Harding, et al.
Cell Transplantation|June 9, 2009
Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human isletsJames D Johnson, Ziliang Ao, Peter Ao, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Measurement of Pro-Islet Amyloid Polypeptide (1-48) in Diabetes and Islet TransplantsJaques A Courtade, Agnieszka M Klimek-Abercrombie, Yi-Chun Chen, et al.
British Journal of Haematology|January 10, 2006
Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myelomaHani Hassoun, Lilian Reich, Virginia M Klimek, et al.
BMJ Open|June 27, 2023
Music to prevent deliriUm during neuroSurgerY (MUSYC): a single-centre, prospective randomised controlled trialPablo R Kappen, M I Mos, Johannes Jeekel, et al.
The Lancet. Haematology|August 1, 2020
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trialJustin Taylor, Xiaoli Mi, Alexander V Penson, et al.
Nature Biotechnology|March 24, 2015
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cellsAndriana G Kotini, Chan-Jung Chang, Ibrahim Boussaad, et al.
Cancer Discovery|March 5, 2014
Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignanciesOmar Abdel-Wahab, Virginia M Klimek, Alisa A Gaskell, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2010
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet graftsK J Potter, A Abedini, P Marek, et al.
Pageof 17